Relief of Pain and Inflammation : Non-Steroidal Anti-inflammatory Agents (NSAID)
OPOTA1 “Potarlon capsule” 250 mg/cap
適應症：類風濕性關節炎，骨關節炎及僵直性脊椎炎之症狀治療。
Usual dose:
Dysmenorrhea: 500 mg followed by 250 mg q6h.
Pain:
Adult (> 14 yrs): 500 mg initially, followed by 250 mg q6h, as needed, with food.
Dose adjustment:
Mefenamic acid is not recommended in p’ts with renal impairment.
Contraindication: See Diclofenac Potassium.
Adverse effect:
Edema, hypertension, myocardial infarction, thrombotic tendency observations, bullous pemphigoid, dermatological finding, drug-induced rash, scaling eczema, Stevens-Johnson syndrome, toxic epidermal necrolysis, aldosterone deficiency, body temperature finding, endocrine finding, hypothermia, metabolic finding, porphyria, colitis, diarrhea, esophagitis, gastrointestinal hemorrhage, gastrointestinal perforation, gastrointestinal tract finding, gastrointestinal ulcer, inflammatory disorder of digestive tract, pancreatitis, steatorrhea, anemia, blood coagulation disorder, granulocytopenia, hematology finding, hemolytic anemia, leukopenia, hepatic necrosis, hepatitis, hepatotoxicity.